Cargando…
Prevention of cervical cancer in HIV-seropositive women from developing countries: a systematic review protocol
BACKGROUND: Over 85% of cervical cancer cases and deaths occur in developing countries. HIV-seropositive women are more likely to develop precancerous lesions that lead to cervical cancer than HIV-negative women. However, the literature on cervical cancer prevention in seropositive women in developi...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5404686/ https://www.ncbi.nlm.nih.gov/pubmed/28438187 http://dx.doi.org/10.1186/s13643-017-0484-9 |
_version_ | 1783231635828768768 |
---|---|
author | Mapanga, Witness Elhakeem, Ahmed Feresu, Shingairai A. Maseko, Fresier Chipato, Tsungai |
author_facet | Mapanga, Witness Elhakeem, Ahmed Feresu, Shingairai A. Maseko, Fresier Chipato, Tsungai |
author_sort | Mapanga, Witness |
collection | PubMed |
description | BACKGROUND: Over 85% of cervical cancer cases and deaths occur in developing countries. HIV-seropositive women are more likely to develop precancerous lesions that lead to cervical cancer than HIV-negative women. However, the literature on cervical cancer prevention in seropositive women in developing countries has not been reviewed. The aim of this study is to systematically review cervical cancer prevention modalities available for HIV-seropositive women in developing countries. METHODS/DESIGN: This protocol was developed by following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Protocols (PRISMA-P) statement, and the systematic review will be reported in accordance with the PRISMA guidelines. Embase, MEDLINE, PubMed, CINAHL and Cochrane Library will be searched from inception up to date of final search, and additional studies will be located through citation and reference list tracking. Eligible studies will be randomised controlled trials, prospective and retrospective cohort studies, case-control and cross-sectional studies carried out in developing countries. Studies will be included if they are published in English and examine cervical cancer prevention modalities in HIV-seropositive women. Results will be summarised in tables and, where appropriate, combined using meta-analysis. DISCUSSION: This review will address the gap in evidence by systematically reviewing the published literature on the different prevention modalities being used to prevent cervical cancer in HIV-seropositive women in developing countries. The findings may be used to inform evidence-based guidelines for prevention of cervical cancer in seropositive women as well as future research. SYSTEMATIC REVIEW REGISTRATION: PROSPERO CRD42017054678. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13643-017-0484-9) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5404686 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-54046862017-04-27 Prevention of cervical cancer in HIV-seropositive women from developing countries: a systematic review protocol Mapanga, Witness Elhakeem, Ahmed Feresu, Shingairai A. Maseko, Fresier Chipato, Tsungai Syst Rev Protocol BACKGROUND: Over 85% of cervical cancer cases and deaths occur in developing countries. HIV-seropositive women are more likely to develop precancerous lesions that lead to cervical cancer than HIV-negative women. However, the literature on cervical cancer prevention in seropositive women in developing countries has not been reviewed. The aim of this study is to systematically review cervical cancer prevention modalities available for HIV-seropositive women in developing countries. METHODS/DESIGN: This protocol was developed by following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Protocols (PRISMA-P) statement, and the systematic review will be reported in accordance with the PRISMA guidelines. Embase, MEDLINE, PubMed, CINAHL and Cochrane Library will be searched from inception up to date of final search, and additional studies will be located through citation and reference list tracking. Eligible studies will be randomised controlled trials, prospective and retrospective cohort studies, case-control and cross-sectional studies carried out in developing countries. Studies will be included if they are published in English and examine cervical cancer prevention modalities in HIV-seropositive women. Results will be summarised in tables and, where appropriate, combined using meta-analysis. DISCUSSION: This review will address the gap in evidence by systematically reviewing the published literature on the different prevention modalities being used to prevent cervical cancer in HIV-seropositive women in developing countries. The findings may be used to inform evidence-based guidelines for prevention of cervical cancer in seropositive women as well as future research. SYSTEMATIC REVIEW REGISTRATION: PROSPERO CRD42017054678. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13643-017-0484-9) contains supplementary material, which is available to authorized users. BioMed Central 2017-04-24 /pmc/articles/PMC5404686/ /pubmed/28438187 http://dx.doi.org/10.1186/s13643-017-0484-9 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Protocol Mapanga, Witness Elhakeem, Ahmed Feresu, Shingairai A. Maseko, Fresier Chipato, Tsungai Prevention of cervical cancer in HIV-seropositive women from developing countries: a systematic review protocol |
title | Prevention of cervical cancer in HIV-seropositive women from developing countries: a systematic review protocol |
title_full | Prevention of cervical cancer in HIV-seropositive women from developing countries: a systematic review protocol |
title_fullStr | Prevention of cervical cancer in HIV-seropositive women from developing countries: a systematic review protocol |
title_full_unstemmed | Prevention of cervical cancer in HIV-seropositive women from developing countries: a systematic review protocol |
title_short | Prevention of cervical cancer in HIV-seropositive women from developing countries: a systematic review protocol |
title_sort | prevention of cervical cancer in hiv-seropositive women from developing countries: a systematic review protocol |
topic | Protocol |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5404686/ https://www.ncbi.nlm.nih.gov/pubmed/28438187 http://dx.doi.org/10.1186/s13643-017-0484-9 |
work_keys_str_mv | AT mapangawitness preventionofcervicalcancerinhivseropositivewomenfromdevelopingcountriesasystematicreviewprotocol AT elhakeemahmed preventionofcervicalcancerinhivseropositivewomenfromdevelopingcountriesasystematicreviewprotocol AT feresushingairaia preventionofcervicalcancerinhivseropositivewomenfromdevelopingcountriesasystematicreviewprotocol AT masekofresier preventionofcervicalcancerinhivseropositivewomenfromdevelopingcountriesasystematicreviewprotocol AT chipatotsungai preventionofcervicalcancerinhivseropositivewomenfromdevelopingcountriesasystematicreviewprotocol |